Literature DB >> 8047620

Magnetic resonance imaging in social phobia.

N L Potts1, J R Davidson, K R Krishnan, P M Doraiswamy.   

Abstract

Recent studies have implicated dopamine and the basal ganglia circuits in the pathophysiology of social phobia. Twenty-two patients who met DSM-III-R criteria for social phobia and 22 age- and sex-matched control subjects underwent magnetic resonance imaging (MRI). MRI was performed with a 1.5 Tesla General Electric Signa System. No statistically significant difference was demonstrated between social phobia patients and normal control subjects in respect to total cerebral, caudate, putamen, and thalamic volumes. Although this study failed to demonstrate any specific cerebral structure abnormalities in patients with social phobia, it did reveal an age-related reduction in putamen volumes in patients with social phobia that was greater than that seen in controls. This age-related reduction in putamen volumes in patients with social phobia was not correlated with the severity of their illness.

Entities:  

Mesh:

Year:  1994        PMID: 8047620     DOI: 10.1016/0165-1781(94)90118-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

1.  Six-month test-retest reliability of MRI-defined PET measures of regional cerebral glucose metabolic rate in selected subcortical structures.

Authors:  S M Schaefer; H C Abercrombie; K A Lindgren; C L Larson; R T Ward; T R Oakes; J E Holden; S B Perlman; P A Turski; R J Davidson
Journal:  Hum Brain Mapp       Date:  2000-05       Impact factor: 5.038

2.  Gray matter abnormalities in social anxiety disorder: primary, replication, and specificity studies.

Authors:  Ardesheer Talati; Spiro P Pantazatos; Franklin R Schneier; Myrna M Weissman; Joy Hirsch
Journal:  Biol Psychiatry       Date:  2012-06-29       Impact factor: 13.382

3.  Grey matter abnormalities in social anxiety disorder: a pilot study.

Authors:  Supriya Syal; Coenraad J Hattingh; Jean-Paul Fouché; Bruce Spottiswoode; Paul D Carey; Christine Lochner; Dan J Stein
Journal:  Metab Brain Dis       Date:  2012-04-22       Impact factor: 3.584

Review 4.  The neurobiology of social phobia: from pharmacotherapy to brain imaging.

Authors:  M Van Ameringen; C Mancini; P Farvolden; J Oakman
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

Review 5.  Neurocircuitry of anxiety disorders.

Authors:  Justine M Kent; Scott L Rauch
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

6.  Increased cortical thickness in a frontoparietal network in social anxiety disorder.

Authors:  Annette Beatrix Brühl; Jürgen Hänggi; Volker Baur; Michael Rufer; Aba Delsignore; Steffi Weidt; Lutz Jäncke; Uwe Herwig
Journal:  Hum Brain Mapp       Date:  2013-09-13       Impact factor: 5.038

7.  Structural and functional connectivity changes in the brain associated with shyness but not with social anxiety.

Authors:  Xun Yang; Keith Maurice Kendrick; Qizhu Wu; Taolin Chen; Sunima Lama; Bochao Cheng; Shiguang Li; Xiaoqi Huang; Qiyong Gong
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

8.  Impairments in goal-directed actions predict treatment response to cognitive-behavioral therapy in social anxiety disorder.

Authors:  Gail A Alvares; Bernard W Balleine; Adam J Guastella
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

9.  Increased amygdalar and hippocampal volumes in young adults with social anxiety.

Authors:  João Paulo Machado-de-Sousa; Flávia de Lima Osório; Andrea P Jackowski; Rodrigo A Bressan; Marcos H N Chagas; Nelson Torro-Alves; André L D Depaula; José A S Crippa; Jaime E C Hallak
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

10.  Insular Volume Reduction in Patients with Social Anxiety Disorder.

Authors:  Akiko Kawaguchi; Kiyotaka Nemoto; Shutaro Nakaaki; Takatsune Kawaguchi; Hirohito Kan; Nobuyuki Arai; Nao Shiraishi; Nobuhiko Hashimoto; Tatsuo Akechi
Journal:  Front Psychiatry       Date:  2016-01-21       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.